Literature DB >> 24705897

SOCS proteins in regulation of receptor tyrosine kinase signaling.

Julhash U Kazi1, Nuzhat N Kabir, Amilcar Flores-Morales, Lars Rönnstrand.   

Abstract

Receptor tyrosine kinases (RTKs) are a family of cell surface receptors that play critical roles in signal transduction from extracellular stimuli. Many in this family of kinases are overexpressed or mutated in human malignancies and thus became an attractive drug target for cancer treatment. The signaling mediated by RTKs must be tightly regulated by interacting proteins including protein-tyrosine phosphatases and ubiquitin ligases. The suppressors of cytokine signaling (SOCS) family proteins are well-known negative regulators of cytokine receptors signaling consisting of eight structurally similar proteins, SOCS1-7, and cytokine-inducible SH2-containing protein (CIS). A key feature of this family of proteins is the presence of an SH2 domain and a SOCS box. Recent studies suggest that SOCS proteins also play a role in RTK signaling. Activation of RTK results in transcriptional activation of SOCS-encoding genes. These proteins associate with RTKs through their SH2 domains and subsequently recruit the E3 ubiquitin machinery through the SOCS box, and thereby limit receptor stability by inducing ubiquitination. In a similar fashion, SOCS proteins negatively regulate mitogenic signaling by RTKs. It is also evident that RTKs can sometimes bypass SOCS regulation and SOCS proteins can even potentiate RTKs-mediated mitogenic signaling. Thus, apart from negative regulation of receptor signaling, SOCS proteins may also influence signaling in other ways.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24705897     DOI: 10.1007/s00018-014-1619-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  106 in total

1.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

2.  Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.

Authors:  F Farabegoli; C Ceccarelli; D Santini; M Taffurelli
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 3.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

4.  Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes.

Authors:  Anne Etienne; Nadine Carbuccia; José Adélaïde; Ismahane Bekhouche; Virginie Rémy; Claudine Sohn; Danielle Sainty; Jean-Albert Gastaut; Sylviane Olschwang; Daniel Birnbaum; Marie-Joëlle Mozziconacci; Max Chaffanet
Journal:  Cancer Genet Cytogenet       Date:  2007-07-01

5.  Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.

Authors:  Walid Sasi; Wen G Jiang; Anup Sharma; Kefah Mokbel
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

6.  Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.

Authors:  Xinyu Qiu; Jianyong Zheng; Xiaodong Guo; Xingchun Gao; Hui Liu; Yanyang Tu; Yongsheng Zhang
Journal:  Mol Cell Biochem       Date:  2013-03-11       Impact factor: 3.396

7.  Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma.

Authors:  Zhuo Li; Dieter Metze; Dorothea Nashan; Carsten Müller-Tidow; Hubert L Serve; Christopher Poremba; Thomas A Luger; Markus Böhm
Journal:  J Invest Dermatol       Date:  2004-10       Impact factor: 8.551

8.  SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone.

Authors:  Kumaran Sundaram; Joseph Senn; Sakamuri V Reddy
Journal:  J Cell Biochem       Date:  2013-09       Impact factor: 4.429

9.  Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1.

Authors:  Edmond M Linossi; Indu R Chandrashekaran; Tatiana B Kolesnik; James M Murphy; Andrew I Webb; Tracy A Willson; Lukasz Kedzierski; Alex N Bullock; Jeffrey J Babon; Raymond S Norton; Nicos A Nicola; Sandra E Nicholson
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

10.  Src-Like adaptor protein (SLAP) binds to the receptor tyrosine kinase Flt3 and modulates receptor stability and downstream signaling.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more
  40 in total

1.  Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.

Authors:  Y Gui; M Yeganeh; Y-C Donates; W-S Tobelaim; W Chababi; M Mayhue; A Yoshimura; S Ramanathan; C Saucier; S Ilangumaran
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

Review 2.  Cell regulation by phosphotyrosine-targeted ubiquitin ligases.

Authors:  Jonathan A Cooper; Tomonori Kaneko; Shawn S C Li
Journal:  Mol Cell Biol       Date:  2015-03-16       Impact factor: 4.272

3.  TLR8 Couples SOCS-1 and Restrains TLR7-Mediated Antiviral Immunity, Exacerbating West Nile Virus Infection in Mice.

Authors:  Amber M Paul; Dhiraj Acharya; Linda Le; Penghua Wang; Dobrivoje S Stokic; A Arturo Leis; Lena Alexopoulou; Terrence Town; Richard A Flavell; Erol Fikrig; Fengwei Bai
Journal:  J Immunol       Date:  2016-10-21       Impact factor: 5.422

4.  Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.

Authors:  M Yeganeh; Y Gui; R Kandhi; D Bobbala; W-S Tobelaim; C Saucier; A Yoshimura; G Ferbeyre; S Ramanathan; S Ilangumaran
Journal:  Oncogene       Date:  2016-01-04       Impact factor: 9.867

Review 5.  The Dark Side of Cell Signaling: Positive Roles for Negative Regulators.

Authors:  Mark A Lemmon; Daniel M Freed; Joseph Schlessinger; Anatoly Kiyatkin
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

6.  Chimeric Peptidomimetics of SOCS 3 Able to Interact with JAK2 as Anti-inflammatory Compounds.

Authors:  Sara La Manna; Laura Lopez-Sanz; Flavia Anna Mercurio; Sara Fortuna; Marilisa Leone; Carmen Gomez-Guerrero; Daniela Marasco
Journal:  ACS Med Chem Lett       Date:  2020-03-19       Impact factor: 4.345

Review 7.  Role of SRC-like adaptor protein (SLAP) in immune and malignant cell signaling.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Lars Rönnstrand
Journal:  Cell Mol Life Sci       Date:  2015-03-13       Impact factor: 9.261

8.  EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis.

Authors:  Jennifer Soler Beatty; Cristina Molnar; Carlos M Luque; Jose F de Celis; María D Martín-Bermudo
Journal:  PLoS Genet       Date:  2021-08-19       Impact factor: 5.917

Review 9.  SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Jianmin Sun; Lars Rönnstrand; Julhash U Kazi
Journal:  Tumour Biol       Date:  2014-08-30

10.  MicroRNA-142-5p facilitates the pathogenesis of ulcerative colitis by regulating SOCS1.

Authors:  Jing Han; Yawei Li; Hong Zhang; Jinbo Guo; Xing Wang; Yaxing Kang; Yuxin Luo; Mengyao Wu; Xiaolan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.